IP Library Granted Patent US 12,122,735
Granted Patent B2
US 12,122,735 · App. 17/987,469 · Granted Oct 22, 2024

Amorphous solid succinylated 3-(fatty acid amido)-2-hydroxy-1- (protected hydroxy)-propane salts and methods of making the same

Inventor: Jennifer Elizabeth Albaneze-Walker (Beerse, BE)
Assignee: Geron Corporation
C07C235/00C07C231/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,122,735
App. No.
17/987,469
Granted
Oct 22, 2024
Kind
B2
Abstract

Aspects of the disclosure includes methods for preparing an amorphous solid composition of a fatty acid metal salt. In practicing the subject methods according to certain embodiments, a succinylated 3-(fatty acid amido)-2-hydroxy-1-(protected hydroxy)-propane organic salt is contacted with a metal base to produce a succinylated 3-(fatty acid amido)-2-hydroxy-1-(protected hydroxy)-propane metal salt; and the succinylated 3-(fatty acid amido)-2-hydroxy-1-(protected hydroxy)-propane metal salt is precipitated in a solvent to produce an amorphous solid succinylated 3-(fatty acid amido)-2-hydroxy-1-(protected hydroxy)-propane metal salt composition. An amorphous solid succinylated 3-(fatty acid amido)-2-hydroxy-1-(protected hydroxy)-propane lithium salt is also provided.

Claims (9)

1. An amorphous solid 3-(fatty acid amido)-2-succinyloxy-1-(protected hydroxy)-propane lithium salt, wherein the fatty acid is selected from the group consisting of palmitic acid, stearic acid, oleic acid, linoleic acid, myristoleic acid and batyl fatty acid.

2. The amorphous salt of claim 1 , wherein the fatty acid is palmitic acid.

3. The amorphous salt of claim 1 , wherein the protected hydroxy group comprises a dimethoxy-triphenylmethyl protecting group.

4. The amorphous salt of claim 1 , wherein the 3-(fatty acid amido)-2-succinyloxy-1-(protected hydroxy)-propane lithium salt is a compound of Formula I:

5. The amorphous salt of claim 4 , having an X-ray powder diffraction pattern (XRPD) comprising a peak in 2θ at about 19.5°.

6. The amorphous salt of claim 4 , wherein thermogravimetric analysis (TGA) of the amorphous salt is characterized by a single weight loss step.

7. The amorphous salt of claim 6 , wherein the weight loss step begins at about 225° C.

8. The amorphous salt of claim 4 , wherein the amorphous salt has a TGA thermogram that shows a mass loss of less than 1% of the total mass of the sample upon heating from 30° C. to 300° C.

9. The amorphous salt of claim 4 , having an absorption peak at about 44.9° C. by differential scanning calorimetry (DSC).

Assignments (4)
PATENT SECURITY AGREEMENT Recorded Nov 12, 2024
From: GERON CORPORATION
To: BIOPHARMA CREDIT PLC [COLLATERAL AGENT]
Reel/Frame 069341/0832 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2023
From: ALBANEZE-WALKER, JENNIFER ELIZABETH
To: JANSSEN PHARMACEUTICA NV
Reel/Frame 062783/0718 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2023
From: JANSSEN PHARMACEUTICA NV
To: JANSSEN BIOTECH, INC.
Reel/Frame 062783/0726 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2023
From: JANSSEN BIOTECH, INC.
To: GERON CORPORATION
Reel/Frame 062783/0737 →
Continuity (3)
Division 17079129 · Oct 23, 2020
Provisional Application 62926778 · Oct 28, 2019
Related Publication 20230192597A1 · Jun 22, 2023